Advertisement

PETQ

PetIQ, Inc.

Healthcare

Set alert

Price alert · PETQ

All alert types
30.98 0.00 0.00%
As of Oct 24, 2024
30.98 Day range 31.00

52-week range unavailable

Open
30.99
Prev close
30.98
Mkt cap
926.64M
Vol
928.27K
Avg vol
0
EPS
0.00
P/E
0.00
Div yield
0.00%
More statistics
Low
30.98
High
31.00
Forward P/E
15.81
Beta
1.74
Short ratio
1.58
Inst. own
102.00%
Dividend
0.00
Ex-div date
Earnings
Nov 5, 2024
50-d avg
30.73
200-d avg
22.52
1y target
30.50

2Y chart

Chart tools
Interval
PETQ two-year price chart7.1313.119.125.131.1Oct 22Mar 23Aug 23Jan 24Jun 24Oct 24

Key statistics

Market cap
926.64M
Enterprise value
1.30B
Trailing P/E
83.73
Forward P/E
15.81
PEG ratio
0.68
Price / sales
0.82
Price / book
3.56
EPS (TTM)
0.37
Beta
1.74
Dividend yield
0.00%
Payout ratio
0.00%
Profit margin
1.16%
Revenue (TTM)
1.13B
Revenue growth
4.60%
Free cash flow
2.18M
Total cash
84.13M
Total debt
460.59M
Return on equity
5.52%
Shares outstanding
29.67M
Short % of float
3.72%
50-day average
30.73
200-day average
22.52

Analyst view

Consensus: buy

Buy
Price target (mean) 30.50 -1.5% downside
Target (low)
30.00
Target (mean)
30.50
Target (high)
31.00
Ratings (0m) 5 4 buy · 1 hold · 0 sell
  • Strong buy2
  • Buy2
  • Hold1
  • Sell0
  • Strong sell0

Next earnings

Nov 5, 2024

Expected Nov 5, 2024. Consensus EPS estimate 0.49.

Earnings history

Financials — quick view

All financials
PETQ Revenue — quarterly 328.94M
2020-Q3 20202020-Q4 20202021-Q1 20212021-Q2 20212021-Q3 20212021-Q4 20212022-Q1 20222022-Q2 20222022-Q3 20222022-Q4 20222023-Q1 20232023-Q2 20232023-Q3 20232023-Q4 20232024-Q1 20242024-Q2 2024
PETQ Net income — quarterly 15.32M
2020-Q3 20202020-Q4 20202021-Q1 20212021-Q2 20212021-Q3 20212021-Q4 20212022-Q1 20222022-Q2 20222022-Q3 20222022-Q4 20222023-Q1 20232023-Q2 20232023-Q3 20232023-Q4 20232024-Q1 20242024-Q2 2024
PETQ EPS — quarterly 0.52
2020-Q3 20202020-Q4 20202021-Q1 20212021-Q2 20212021-Q3 20212021-Q4 20212022-Q1 20222022-Q2 20222022-Q3 20222022-Q4 20222023-Q1 20232023-Q2 20232023-Q3 20232023-Q4 20232024-Q1 20242024-Q2 2024

Earnings

PETQ recent earnings
Report dateQuarter endingEPS estimateEPS reportedSurpriseSurprise %
Nov 5, 2024Sep 1, 20240.36———
Aug 7, 2024Jun 1, 20240.49———
May 8, 2024Mar 1, 20240.42———
Feb 28, 2024Dec 1, 2023-0.29———
Nov 7, 2023Sep 1, 20230.03———
Aug 8, 2023Jun 1, 20230.26———

Upgrades / downgrades

PETQ analyst upgrades and downgrades
DateFirmActionFromTo
Aug 8, 2024Truist SecuritiesdownBuyHold
May 10, 2024BenchmarkreitBuyBuy
Mar 19, 2024JefferiesmainBuyBuy
Dec 19, 2023Jefferiesinit—Buy
Oct 2, 2023Truist SecuritiesmainBuyBuy
Sep 6, 2023Lake Streetinit—Buy

About PetIQ, Inc.

PetIQ, Inc. operates as a pet medication and wellness company in the United States and internationally. It operates in two segments, Products and Services. The company offers Rx pet medications, which sells flea and tick control, heartworm preventatives, arthritis, thyroid, diabetes and pain treatments, antibiotics, and other specialty medications; and develops and manufactures its own proprietary value-branded products, as well as third-party branded products for dogs and cats. It also provides OTC medications and supplies primarily within the flea and tick control, dog dewormers, and behavior management categories of the health and wellness industry in various forms, such as spot on (topical) treatments, chewables, oral tablets, and collars. In addition, the company offers health and wellness products that include dog and cat treats, oral health solutions, stain and odor treatments, and pet nutritional supplements under the PetArmor®, Rocco & Roxie®, VetIQ®, Minties® and Sentry® brands. It provides its products primarily under the PetIQ, PetArmor, VIP Petcare, VetIQ PetCare, VetIQ, Capstar, Advecta, SENTRY, Sergeants, PurLuv, Rocco & Roxie, Minties, Heart Shield Plus, and TruProfen brand names. In addition, the company operates veterinarian service platform through community clinics, pop-up locations, wellness centers, and permanent locations that offer cost effective and convenient veterinary wellness services, including diagnostic tests, vaccinations, prescription medications, microchipping, grooming and hygiene, and wellness checks; and provides veterinary care services. It operates through veterinarian, retail, and e-commerce channels. PetIQ, Inc. was founded in 2010 and is headquartered in Eagle, Idaho. As of October 25, 2024, PetIQ, Inc. was taken private.

Sector
Healthcare
Industry
Drug Manufacturers - Specialty & Generic
Country
United States
Website
petiq.com

News

Your note

Sign in to keep a note on PETQ — it syncs with the Stock Master app.

Insider holders

PETQ insider holders
InsiderRelationLatest transactionDateShares held
CARTER WILLIAM JOHNGeneral CounselConversion of Exercise of derivative securityAug 27, 20243,497
CHRISTENSEN MCCORDChief Executive OfficerConversion of Exercise of derivative securityOct 24, 20240
FIRST MARK LDirectorConversion of Exercise of derivative securityJun 20, 202418,547
HALL ALLANDirectorConversion of Exercise of derivative securityJun 20, 202412,807
HUFF SCOTTDirectorConversion of Exercise of derivative securityJun 20, 202418,194
LEFKO KIMBERLYDirectorConversion of Exercise of derivative securityJun 20, 202414,822

Institution ownership

PETQ institution ownership
Holder% heldSharesValueReported
Blackrock Inc.10.14%3,009,66193.24MJun 29, 2024
Vanguard Group Inc7.39%2,191,95667.91MJun 29, 2024
Eos Management, L.P.6.65%1,972,68761.11MJun 29, 2024
Dimensional Fund Advisors LP4.17%1,236,63238.31MJun 29, 2024
Aristotle Capital Boston, LLC4.15%1,232,59038.19MJun 29, 2024
Boston Partners3.51%1,039,98732.22MJun 29, 2024

Fund ownership

PETQ fund ownership
Holder% heldSharesValueReported
Vanguard Total Stock Market Index Fund2.78%826,06725.59MJun 29, 2024
iShares Russell 2000 ETF2.37%703,08321.78MSep 29, 2024
Thornburg Small/Mid Cap Core Fund2.15%637,97519.76MJun 29, 2024
Arbitrage Fund1.54%458,00814.19MAug 30, 2024
Vanguard Extended Market Index Fund1.38%408,88212.67MJun 29, 2024
Oberweis Micro-Cap Portfolio1.15%340,70010.55MJun 29, 2024
Advertisement